PCV33- COST-EFFECTIVENESS ANALYSIS OF SIMVASTATIN AND LOVASTATIN/EXTENDED-RELEASE NIACIN TO ACHIEVE LDLAND HDL GOAL USING NHANES DATA
May 1, 2003, 00:00 AM
10.1016/S1098-3015(10)64147-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)64147-2/fulltext
Section Title :
Section Order :
348
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64147-2&doi=10.1016/S1098-3015(10)64147-2